AIM ImmunoTech Inc. AIM
Nov 11, 2026, 1:46 PM EST
- YTD
- -86.03%
- 1 year
- -89.95%
Discussion (221)
Sign in to join the discussion
TO THA MOON!
JUST RELEASED!
AIM said it will work with its contract research organization, Amarex Clinical Research LLC, to seek Food and Drug Administration fast-track and possibly FDA breakthrough designations.
B O O M ! ! !
AIM said it will work with its contract research organization, Amarex Clinical Research LLC, to seek Food and Drug Administration fast-track and possibly FDA breakthrough designations.
IN DAYS, you will see just how CRAZY this discount was!
BUYING here is like WINNING the lottery. EXCEPT, you ALREADY KNOW you have a WINNER!
THIS is why the ROLL THE DICE on BIOTECH. Reward here could be 1500X!
VERY EASILY, this could jump to $90, and continue running PAST $1,000!
NO Ifs, Ands, or Buts about it. This is a guaranteed 10x, or $20, in VERY SHORT ORDER! The true move with be in the 100s!
ODDS of a buyout by big pharma just GREW 100,000 FOLD!